The serine protease inhibitor elafin maintains normal growth control by opposing the mitogenic effects of neutrophil elastase
Crossref DOI link: https://doi.org/10.1038/onc.2014.284
Published Online: 2014-09-08
Published Print: 2015-07
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Caruso, J A
Akli, S
Pageon, L
Hunt, K K
Keyomarsi, K
Text and Data Mining valid from 2014-09-08
Version of Record valid from 2014-09-08
Article History
Received: 30 January 2014
Revised: 22 June 2014
Accepted: 19 July 2014
First Online: 8 September 2014
Competing interests
: The authors declare no conflict of interest.